BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 9041357)

  • 61. Identification of Entamoeba histolytica and E. dispar infection in Maceió, Alagoas State, northeast Brazil.
    Santos RV; Fontes G; Duarte IA; Santos-Júnior JA; Rocha EM
    J Infect Dev Ctries; 2016 Oct; 10(10):1146-1150. PubMed ID: 27801380
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MicroRNAs expression of patients infected with Entamoeba histolytica in association with Entamoeba dispar isolated from liquid stool.
    Ahmad NA
    Ann Parasitol; 2021; 67(4):805-812. PubMed ID: 35339120
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Comparison of direct microscopy, culture, ELISA and molecular methods for diagnosis of Entamoeba histolytica].
    Tüzemen NU; Doğan N
    Mikrobiyol Bul; 2014 Jan; 48(1):114-22. PubMed ID: 24506721
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Entamoeba moshkovskii and Entamoeba dispar-associated infections in pondicherry, India.
    Parija SC; Khairnar K
    J Health Popul Nutr; 2005 Sep; 23(3):292-5. PubMed ID: 16262027
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Amebiasis and comparison of microscopy to ELISA technique in detection of Entamoeba histolytica and Entamoeba dispar.
    Nesbitt RA; Mosha FW; Katki HA; Ashraf M; Assenga C; Lee CM
    J Natl Med Assoc; 2004 May; 96(5):671-7. PubMed ID: 15160983
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Study of human Entamoeba histolytica infection by zymodeme, indirect hemagglutination and electroimmunotransfer blot assays.
    Sánchez-Guillén MC; Argüello-García R; Garduño G; Valadez-Salazar A; Martínez-García MC; Muñoz O; Ortega-Pierres MG
    Arch Invest Med (Mex); 1990; 21 Suppl 1():209-15. PubMed ID: 2136487
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Frequency and molecular characterisation of Entamoeba histolytica, Entamoeba dispar, Entamoeba moshkovskii, and Entamoeba hartmanni in the context of water scarcity in northeastern Brazil.
    Calegar DA; Nunes BC; Monteiro KJ; Santos JP; Toma HK; Gomes TF; Lima MM; Bóia MN; Carvalho-Costa FA
    Mem Inst Oswaldo Cruz; 2016 Feb; 111(2):114-9. PubMed ID: 26841049
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Copro-molecular study of Entamoeba infection among the indigenous community in Malaysia: A first report on the species-specific prevalence of Entamoeba in dogs.
    Ngui R; Hassan NA; Nordin NMS; Mohd-Shaharuddin N; Chang LY; Teh CSJ; Chua KH; Kee BP; Hoe SZ; Lim YAL
    Acta Trop; 2020 Apr; 204():105334. PubMed ID: 31926914
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Public health and clinical importance of amoebiasis in Malaysia: a review.
    Tengku SA; Norhayati M
    Trop Biomed; 2011 Aug; 28(2):194-222. PubMed ID: 22041740
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular differentiation of Entamoeba histolytica and Entamoeba dispar from Tunisian food handlers with amoeba infection initially diagnosed by microscopy.
    Ben Ayed S; Ben AR; Mousli M; Aoun K; Thellier M; Bouratbine A
    Parasite; 2008 Mar; 15(1):65-8. PubMed ID: 18416248
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intestinal antilectin immunoglobulin A antibody response and immunity to Entamoeba dispar infection following cure of amebic liver abscess.
    Ravdin JI; Abd-Alla MD; Welles SL; Reddy S; Jackson TF
    Infect Immun; 2003 Dec; 71(12):6899-905. PubMed ID: 14638778
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevalence and risk factors for infection with Entamoeba histolytica/dispar/ moshkovskii complex in people living in the slightest and outermost islands of Indonesia.
    Junaidi -; Asmaruddin MS; Kurrohman T; Nurdin -; Khazanah W
    Trop Biomed; 2023 Jun; 40(2):160-164. PubMed ID: 37650401
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Cross-Sectional Study of
    Soares NM; Azevedo HC; Pacheco FTF; de Souza JN; Del-Rei RP; Teixeira MCA; Santos FLN
    Biomed Res Int; 2019; 2019():7523670. PubMed ID: 31428644
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Use of molecular tools to distinguish Entamoeba histolytica and Entamoeba dispar infection among the aborigines in Cameron Highlands.
    Noor Azian MY; Lokman Hakim S; Maslawaty MN
    Trop Biomed; 2006 Jun; 23(1):31-6. PubMed ID: 17041549
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Entamoeba histolytica infection in children and protection from subsequent amebiasis.
    Haque R; Mondal D; Duggal P; Kabir M; Roy S; Farr BM; Sack RB; Petri WA
    Infect Immun; 2006 Feb; 74(2):904-9. PubMed ID: 16428733
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Entamoeba histolytica and Entamoeba dispar are distinct species; clinical, epidemiological and serological evidence.
    Jackson TF
    Int J Parasitol; 1998 Jan; 28(1):181-6. PubMed ID: 9504344
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Entamoeba histolytica and Entamoeba dispar: comparison of two PCR assays for diagnosis in a non-endemic setting.
    Calderaro A; Gorrini C; Bommezzadri S; Piccolo G; Dettori G; Chezzi C
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):450-7. PubMed ID: 16274714
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Determination of Entamoeba histolytica infection in patients from Greater Metropolitan Belém, Para, Brazil, by enzyme-linked immunosorbent assay (ELISA) for antigen detection].
    Silva MC; Monteiro Cdo S; Araújo Bdos A; Silva JV; Póvoa MM
    Cad Saude Publica; 2005; 21(3):969-73. PubMed ID: 15868057
    [TBL] [Abstract][Full Text] [Related]  

  • 79. '
    Quispe-Rodríguez GH; Wankewicz AA; Luis Málaga Granda J; Lewis B; Stockert K; Clinton White A
    Trop Doct; 2020 Jan; 50(1):19-22. PubMed ID: 31600122
    [No Abstract]   [Full Text] [Related]  

  • 80. Molecular prevalence of Entamoeba histolytica/dispar infection among patients attending four health centres in north-west Ethiopia.
    Yimer M; Zenebe Y; Mulu W; Abera B; Saugar JM
    Trop Doct; 2017 Jan; 47(1):11-15. PubMed ID: 26834117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.